Literature DB >> 8510081

von Willebrand factor and endothelial damage in essential hypertension.

A D Blann1, T Naqvi, M Waite, C N McCollum.   

Abstract

The relationship between von Willebrand factor antigen (vWFAg, a specific endothelial cell product) and hypertension was examined. Circulating vWFAg levels were measured in serum from patients attending a hypertension clinic and in normotensive controls. The vWFAg was higher in those patients with uncontrolled hypertension at 131 +/- 34 IU/dl than in controls (90 +/- 30 IU/dl) and in those whose hypertension was controlled 104 +/- 29 IU/dl (P < 0.001). Levels of vWFAg correlated with both SBP (r = 0.42, P < 0.0002) and DBP (r = 0.25, P < 0.05), but serum from neither group of patients was more cytotoxic to cultured endothelial cells in vitro than was serum from controls. Neither symptoms of cardiovascular or peripheral vascular disease or two of its risk factors (hypercholesterolaemia or smoking, alone or in combination) appeared to further increase vWFAg in patients with uncontrolled hypertension. However, vascular disease and the same risk factors did increase vWFAg to 133 +/- 36 IU/dl in those patients with controlled hypertension (P < 0.001). These data indicate a relationship between vWFAg and hypertension and suggest that endothelial damage may indeed be important in the vascular complications of hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510081

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  17 in total

Review 1.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

2.  Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

Authors:  M C Nash; V Shah; M J Dillon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

3.  Prevalence and Risk Factors Associated With Hypertension in von Willebrand Disease.

Authors:  Mariya H Apostolova; Craig D Seaman; Diane M Comer; Jonathan G Yabes; Margaret V Ragni
Journal:  Clin Appl Thromb Hemost       Date:  2016-09-21       Impact factor: 2.389

4.  Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways.

Authors:  Yan Xiong; Zhenqian Hu; Xiaofan Han; Beibei Jiang; Rongli Zhang; Xiaoyu Zhang; Yao Lu; Chenyang Geng; Wei Li; Yulong He; Yingqing Huo; Masabumi Shibuya; Jincai Luo
Journal:  Cell Res       Date:  2013-04-23       Impact factor: 25.617

Review 5.  von Willebrand factor and its relevance to cardiovascular disorders.

Authors:  G Y Lip; A D Blann
Journal:  Br Heart J       Date:  1995-12

6.  Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.

Authors:  Laszlo Szapary; Beata Horvath; Zsolt Marton; Tamas Alexy; Gabor Kesmarky; Tamas Habon; Monika Szots; Katalin Koltai; Istvan Juricskay; Jozsef Czopf; Kalman Toth
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Association of von Willebrand factor blood levels with exercise hypertension.

Authors:  Sonja B Nikolic; Murray J Adams; Petr Otahal; Lindsay M Edwards; James E Sharman
Journal:  Eur J Appl Physiol       Date:  2014-12-25       Impact factor: 3.078

8.  Plasma Levels of Nitrites/Nitrates in Patients with Chronic Atrial Fibrillation are Increased after Electrical Restoration of Sinus Rhythm.

Authors:  Dragana Nikitovic; Evangelos A Zacharis; Emmanuel G Manios; Nikki E Malliaraki; Emmanuel M Kanoupakis; Katerina I Sfiridaki; Emmanuel I Skalidis; Andreas N Margioris; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

9.  Haemostatic markers are associated with measures of vascular disease in adults with hypertension.

Authors:  M Khaleghi; L A Singletary; V Kondragunta; K R Bailey; S T Turner; T H Mosley; I J Kullo
Journal:  J Hum Hypertens       Date:  2009-01-29       Impact factor: 3.012

10.  Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.

Authors:  L M Fatti; B Bottasso; C Invitti; R Coppola; F Cavagnini; P M Mannucci
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 5.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.